Solid Biosciences Inc (NAS:SLDB)
$ 9.12 0.17 (1.9%) Market Cap: 350.02 Mil Enterprise Value: 163.25 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 40/100

Solid Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 05:45PM GMT
Release Date Price: $7.7 (-4.82%)
Anupam Rama JPMorgan Chase;Co.;Analyst

&-

42 Annual JPMorgan Healthcare Conference. My name is Anupam Rama, one of the senior biotech analyst here at JPMorgan. And I'm joined by my squad Laurel Hall, Dan Grover, Malcolm Kuno. Our next presenting company is Solid Bio presenting on behalf of the Company, we have CEO Bo Cumbo.

Bo Cumbo Solid Biosciences Inc.;President;CEO

&

Yeah, thank you very much, Anupam, and thank you, JPMorgan for the invitation, really do appreciate . I'm gonna be making a number of forward-looking statements today. Please take time to look the forward looking statements on the deck.

We also part on the AK. Obviously, our results may vary. So please take a moment to read this. So today, we're going to be talking about our -- really the transformative changes that we've made over the last year. It really leading platform partners, pipeline management and a very strong balance sheet.

Our management team, we just recently added our new Chief Medical Officer, Dr. Gabriel

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot